Shopping Cart
Remove All
Your shopping cart is currently empty
Tividenofusp alfa (DNL-310) is a fusion protein created by combining IDS with Denali's proprietary Enzyme Transport Vehicle (ETV).
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $452 | 2-4 weeks | 2-4 weeks | |
| 5 mg | $1,330 | 2-4 weeks | 2-4 weeks | |
| 10 mg | $2,130 | 2-4 weeks | 2-4 weeks |
| Description | Tividenofusp alfa (DNL-310) is a fusion protein created by combining IDS with Denali's proprietary Enzyme Transport Vehicle (ETV). |
| Synonyms | DNL-310 |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 2641020-57-5 |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.